Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
Video
Survival at ‘overweight’ BMI surpasses ‘normal’
PARIS – Data from more than 142,000 middle-aged people worldwide show those with a body mass index of 25-29 kg/m2 outlast those at 20-...
News
Ubrogepant shows acute migraine efficacy in triptan nonresponders
PHILADELPHIA – Data from two ubrogepant pivotal trials showed similar migraine pain relief in triptan-ineffective and triptan-effective patients...
News
Asthma hospitalization in kids linked with doubled migraine incidence
PHILADELPHIA – Data from 11 million U.S. pediatric inpatients showed a doubled rate of migraine diagnoses among kids hospitalized for asthma.
Video
Quarterly intravenous eptinezumab prevents migraine
PHILADELPHIA – Results from a pair of dose-ranging, randomized studies showed one IV eptinezumab dose cut migraine recurrences for 3 months.
News
FDA advisors recommend nintedanib for SSc interstitial lung disease
The positive outcome in nintedanib’s pivotal trial and prior FDA approval for idiopathic pulmonary fibrosis swayed panel members.
News
Atogepant shows safety, efficacy for migraine prevention
PHILADELPHIA – Atogepant is the first drug from its small-molecule class to undergo advanced clinical testing for migraine prevention.
News
Lymphoma risk prompts FDA recall of Allergan’s textured breast implants
The FDA asked Allergan to recall six brands of textured breast implants and expanders because of the lymphoma risk they pose.
News
Medication overuse prevalent among U.S. migraine patients
PHILADELPHIA – Results from a U.S. survey showed an 18% prevalence of medication overuse among people with self-reported migraine symptoms.
News
Perioperative scripts for migraine abortive drugs linked with fewer pain readmissions
PHILADELPHIA - Migraine patients who underwent any surgery and then received a prescription for a migraine abortive drug had fewer 30-day pain...
Video
Telemedicine migraine consults are as effective as in-office visits
PHILADELPHIA - Follow-up telemedicine consultations with migraine patients produced outcomes similar to patients managed in office in a randomized...